ACCESSION: MSBNK-SMB_Measured-HSA001P0199028
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.14, Processed 2025.02.21, Annotated 2025.04.02, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyushu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 16
COMMENT: RAW_SPEC {'BLK01_7206': {'bp': 373350.0, 'sum': 1648056.0}, 'BLK01_7731': {'bp': 314062.0, 'sum': 1446853.0}, 'BLK01_7270': {'bp': 322601.0, 'sum': 1514797.0}, 'BLK01_7334': {'bp': 352951.0, 'sum': 1626832.0}, 'BLK01_7796': {'bp': 307197.0, 'sum': 1404586.0}, 'BLK01_7672': {'bp': 339550.0, 'sum': 1512556.0}, 'BLK01_7923': {'bp': 282913.0, 'sum': 1348810.0}, 'BLK01_7859': {'bp': 301468.0, 'sum': 1373292.0}, 'BLK01_7082': {'bp': 334674.0, 'sum': 1585014.0}, 'BLK01_7587': {'bp': 344031.0, 'sum': 1535287.0}, 'BLK01_7398': {'bp': 335710.0, 'sum': 1503479.0}, 'BLK01_7459': {'bp': 286341.0, 'sum': 1279483.0}, 'BLK01_6853': {'bp': 353572.0, 'sum': 1631352.0}, 'BLK01_6977': {'bp': 322644.0, 'sum': 1486565.0}, 'BLK01_7143': {'bp': 307647.0, 'sum': 1406627.0}, 'BLK01_7522': {'bp': 360742.0, 'sum': 1549680.0}}
COMMENT: RETENTION_TIME_STDEV 0.648
COMMENT: PRECURSOR_M/Z_RAW 199.154887
COMMENT: PRECURSOR_M/Z_STDEV 0.000058
COMMENT: PRECURSOR_IN_MS1 mz 199.155227; int 65.659; delta(ppm) 1.035546
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M+NH4; M+H; mz 182.128705; int 5.268; cor 0.665
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.621; C9H18N4O; [M+H]+; delta(ppm) -0.620748
COMMENT: PROPOSED_MF SevenGoldenRules 0.668; C9H15N3O; [M+NH4]+; delta(ppm) -0.668060
COMMENT: PROPOSED_MF MS-FINDER 2.790; C9H15N3O; [M+NH4]+; delta(ppm) -0.620911
COMMENT: PROPOSED_MF MS-FINDER 2.756; C9H18N4O; [M+H]+; delta(ppm) -0.620911
COMMENT: PROPOSED_MF SIRIUS5_Sirius 8.239; C9H18N4O; [M+H]+; delta(ppm) -0.620911
COMMENT: PROPOSED_MF SIRIUS5_Sirius 8.239; C9H15N3O; [M+H3N+H]+; delta(ppm) -0.620911
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C9H18N4O; [M+H]+; delta(ppm) -0.620911
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C9H15N3O; [M+H3N+H]+; delta(ppm) -0.620911
COMMENT: PROPOSED_MF SIRIUS6_Sirius 22.407; C9H18N4O; [M+H]+; delta(ppm) -0.620911
COMMENT: PROPOSED_MF SIRIUS6_Sirius 22.407; C9H15N3O; [M+H3N+H]+; delta(ppm) -0.620911
COMMENT: PROPOSED_MF SIRIUS6_Sirius 6.651; C6H16FN3O2; [M+H3N+H]+; delta(ppm) -6.358375
COMMENT: PROPOSED_MF SIRIUS6_Sirius 6.065; C4H14FN6O; [M+H3N+H]+; delta(ppm) 0.383380
COMMENT: PROPOSED_MF SIRIUS6_Sirius 5.535; C11H20NO2; [M+H]+; delta(ppm) -7.362652
COMMENT: PROPOSED_MF SIRIUS6_Sirius 5.535; C11H17O2; [M+H3N+H]+; delta(ppm) -7.362652
COMMENT: PROPOSED_MF SIRIUS6_Sirius 3.278; C7H16N7; [M+H]+; delta(ppm) 6.120921
COMMENT: PROPOSED_MF SIRIUS6_Sirius 3.278; C7H13N6; [M+H3N+H]+; delta(ppm) 6.120921
COMMENT: PROPOSED_MF SIRIUS6_Sirius -8.749; C3H16N7P; [M+H3N+H]+; delta(ppm) 4.568833
COMMENT: PROPOSED_MF SIRIUS6_Sirius -11.073; C5H18N4OP; [M+H3N+H]+; delta(ppm) -2.172978
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C9H18N4O; [M+H]+; delta(ppm) -0.620911
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C9H15N3O; [M+H3N+H]+; delta(ppm) -0.620911
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.360; YLJXZSWHZFXCDY-JHPDDGAFNA-N; [M+H]+; N[C@H]1CC[C@H](C1)C(=O)NCCC(N)=N
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.556; YLJXZSWHZFXCDY-JHPDDGAFNA-N; [M+H]+; Amidinomycin;Amidinomycine;HU 1/68;Myxoviromycin
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.535; NQCPECCCWDWTJJ-UHFFFAOYSA-N; [M+NH4]+; 2-diethylamino-6-methylpyrimidin-4(1H)-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.504; PGZWFWGPWUBXAZ-QMMMGPOBSA-N; [M+NH4]+; (2S)-N-(cyanomethyl)-1-ethylpyrrolidine-2-carboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.431; ZNXAJGZPUQOEDZ-UHFFFAOYSA-N; [M+NH4]+; 6-ethyl-4,5,7,8-tetrahydro-[1,3]oxazolo[4,5-d]azepin-2-amine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.404; MGESDKOHGQHZFN-UHFFFAOYSA-N; [M+NH4]+; 5-(aminomethyl)-4-(methoxymethyl)-2-methylpyridin-3-amine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.312; ZIJBPFPFSGVPTO-UHFFFAOYSA-N; [M+NH4]+; 2-amino-6-(3-methylbutyl)-3,4-dihydropyrimidin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; YLJXZSWHZFXCDY-JHPDDGAFNA-N; [M+H]+; Amidinomycin;Amidinomycine;HU 1/68;Myxoviromycin
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; ZIJBPFPFSGVPTO-UHFFFAOYSA-N; [M+NH4]+; 2-amino-6-(3-methylbutyl)-3,4-dihydropyrimidin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.876; NQCPECCCWDWTJJ-UHFFFAOYSA-N; [M+NH4]+; 2-diethylamino-6-methylpyrimidin-4(1H)-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.870; PGZWFWGPWUBXAZ-QMMMGPOBSA-N; [M+NH4]+; (2S)-N-(cyanomethyl)-1-ethylpyrrolidine-2-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.365; ZNXAJGZPUQOEDZ-UHFFFAOYSA-N; [M+NH4]+; 6-ethyl-4,5,7,8-tetrahydro-[1,3]oxazolo[4,5-d]azepin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.221; MGESDKOHGQHZFN-UHFFFAOYSA-N; [M+NH4]+; 5-(aminomethyl)-4-(methoxymethyl)-2-methylpyridin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.888; YLJXZSWHZFXCDY-RQJHMYQMSA-N; [M+H]+; (1R,3S)-3-amino-N-(3-amino-3-iminopropyl)cyclopentane-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.093; ZNXAJGZPUQOEDZ-UHFFFAOYSA-N; [M+NH4]+; 6-ethyl-4,5,7,8-tetrahydro-[1,3]oxazolo[4,5-d]azepin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.010; OOZJHQLYZLXPIF-UHFFFAOYSA-N; [M+H]+; 3-(azidomethyl)-1-hydroxy-2,2,5,5-tetramethylpyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.990; NQCPECCCWDWTJJ-UHFFFAOYSA-N; [M+NH4]+; 2-(diethylamino)-4-methyl-1H-pyrimidin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.823; VYCNDBQWMCGZAA-UHFFFAOYSA-N; [M+NH4]+; 2-amino-5-butyl-4-methyl-1H-pyrimidin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.207; HCBVNRIFWSZMKU-UHFFFAOYSA-N; [M+NH4]+; 2-(4-amino-4,5,6,7-tetrahydroindazol-1-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.188; DQENLXHRPLSILC-UHFFFAOYSA-N; [M+NH4]+; 4-amino-5-pentyl-1H-pyrimidin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.174; GXYDRMDRTXLIHI-UHFFFAOYSA-N; [M+NH4]+; 5-(aminomethyl)-3,4-diethyl-1H-pyridazin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.106; RYNLBXYARMGYPC-UHFFFAOYSA-N; [M+NH4]+; 4-amino-5-butyl-2-methyl-1H-pyrimidin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.071; QXNSDFXNTPPPMD-JGVFFNPUSA-N; [M+NH4]+; [(3S,4S)-4-(3-methylimidazol-4-yl)pyrrolidin-3-yl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.071; GZIQHUCQRGBGBE-UHFFFAOYSA-N; [M+NH4]+; 1-[(4-aminopyridin-2-yl)amino]-2-methylpropan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.035; KDHIXBKIBCKZQU-UHFFFAOYSA-N; [M+NH4]+; 4-(1-methylimidazol-2-yl)piperidin-4-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.983; HMELYHQGWKUPAH-UHFFFAOYSA-N; [M+NH4]+; 4-(2-methylpyrazol-3-yl)piperidin-4-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.979; KBRISCUGMBXEQV-UHFFFAOYSA-N; [M+NH4]+; 4-(1-methylpyrazol-4-yl)piperidin-4-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.977; SGVSDXUFVJGQOJ-UHFFFAOYSA-N; [M+NH4]+; 1H-imidazol-2-yl(piperidin-4-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.750; HGZOYFLXLKNJHY-UHFFFAOYSA-N; [M+NH4]+; 3-[2-(2-oxopyrrolidin-1-yl)ethylamino]propanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.706; HHJDARBBDLVPJM-UHFFFAOYSA-N; [M+NH4]+; 5-N-(2-methoxyethyl)-5-N-methylpyridine-2,5-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.698; XXIODYOSZOJCLL-UHFFFAOYSA-N; [M+NH4]+; 3-ethyl-5-piperidin-3-yl-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.669; OOFRPEDNTOJVQY-UHFFFAOYSA-N; [M+NH4]+; 3-(3,5-dimethyl-1H-pyrazol-4-yl)morpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.656; GMHNKGPHJQRSMQ-UHFFFAOYSA-N; [M+NH4]+; 5-methyl-1-(oxan-4-yl)pyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.656; VPIPHCYJMTYWDB-UHFFFAOYSA-N; [M+NH4]+; 3-methyl-1-(oxan-4-yl)pyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.634; DWMYGDSJFUBVKQ-UHFFFAOYSA-N; [M+NH4]+; 1-methyl-5-(oxan-4-yl)pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.610; CQTKVYHURMMRPR-UHFFFAOYSA-N; [M+NH4]+; 2-(2-pyrrolidin-2-ylpropyl)-1,3,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.602; KIJUVFXYFIUKHM-UHFFFAOYSA-N; [M+NH4]+; 1-propyl-6,7-dihydro-4H-pyrano[3,4-d]imidazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.601; VBBBTQSQJTVDDF-UHFFFAOYSA-N; [M+NH4]+; 4-methyl-5-(oxan-4-yl)-1H-pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.596; VWQGOQSMLIKZKR-UHFFFAOYSA-N; [M+NH4]+; 1-(5-methyl-1,2,4-oxadiazol-3-yl)cyclohexan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.589; SFUBOCVBYZCIFG-UHFFFAOYSA-N; [M+NH4]+; 5-methyl-2-(oxan-4-yl)pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.587; QSCAGDQZSRZPOH-UHFFFAOYSA-N; [M+NH4]+; 1-methyl-N-(oxan-4-yl)pyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.585; XPNWLCXGUBWJGX-UHFFFAOYSA-N; [M+NH4]+; 3-methyl-5-(4-methylpiperidin-4-yl)-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.574; HSCWDVRVHYGIFA-UHFFFAOYSA-N; [M+NH4]+; 5-amino-1-[2-(dimethylamino)ethyl]pyridin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.571; BIOMFDHHARGJFB-UHFFFAOYSA-N; [M+NH4]+; 4-(3-methyl-1,2,4-oxadiazol-5-yl)cyclohexan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.571; YONREVWIEOKSMK-UHFFFAOYSA-N; [M+NH4]+; 3-(azepan-2-yl)-5-methyl-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.565; JTINBOGNUWUGGZ-UHFFFAOYSA-N; [M+NH4]+; 5-ethyl-3-piperidin-2-yl-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.558; BZFBHNLGVKEULM-UHFFFAOYSA-N; [M+NH4]+; 2-(1-methylimidazol-2-yl)oxan-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.556; MUWLMGYRXAWPAY-UHFFFAOYSA-N; [M+NH4]+; 3-(3-ethyl-1,2,4-oxadiazol-5-yl)cyclopentan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.554; VNTQVHBPLVELRW-UHFFFAOYSA-N; [M+NH4]+; 2-(4-ethyl-1H-pyrazol-5-yl)morpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.554; IMEFHYRQGSBUQA-BDAKNGLRSA-N; [M+NH4]+; (2S,3R)-2-(1,5-dimethylpyrazol-4-yl)oxolan-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.552; FNHCEZVALREEJW-UHFFFAOYSA-N; [M+NH4]+; 2-methyl-5-(oxan-4-yl)pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.545; VINYJNGGVYOFMO-UHFFFAOYSA-N; [M+NH4]+; 2-[2-(dimethylamino)ethoxy]pyridin-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.541; GQUXEPBUPCLZTC-UHFFFAOYSA-N; [M+NH4]+; 1-(2-methoxyethyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.538; ALMLRHBBDXINTB-UHFFFAOYSA-N; [M+NH4]+; 5-methyl-4-(piperazin-1-ylmethyl)-1,3-oxazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.536; UIVPKOOMHSYUNJ-UHFFFAOYSA-N; [M+NH4]+; 5-methyl-3-(piperidin-3-ylmethyl)-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.522; WKTDGUSTKNDUEI-UHFFFAOYSA-N; [M+NH4]+; 5-propan-2-yl-3-pyrrolidin-2-yl-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.477; UHKUQSBZFWWHQL-UHFFFAOYSA-N; [M+NH4]+; 1-(2-amino-3-methylbutanoyl)azetidine-2-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.472; IVCVUYGTIKYXFG-UHFFFAOYSA-N; [M+NH4]+; 2-[4-(oxolan-3-yl)pyrazol-1-yl]ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.446; QZKNQIWHWNZUPG-UHFFFAOYSA-N; [M+NH4]+; 2-methyl-2-(1-methylpyrazol-4-yl)morpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.444; FSYSYUOZJAUBEU-UHFFFAOYSA-N; [M+NH4]+; 2-(2-methylpyrazol-3-yl)oxan-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.362; RFHQJLOTULCXTL-IONNQARKSA-N; [M+NH4]+; [(2R,3S)-2-(2-methylpyrazol-3-yl)oxolan-3-yl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.360; YPJOOPMYFLEHFQ-UHFFFAOYSA-N; [M+NH4]+; [2-(1-methylpyrazol-4-yl)oxolan-2-yl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.359; UROOQQFWCQYSFT-UHFFFAOYSA-N; [M+NH4]+; 2-(3-methylimidazol-4-yl)oxan-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.358; LUJBSCAJUSLCOU-UHFFFAOYSA-N; [M+NH4]+; 2-(1-methylpyrazol-4-yl)oxan-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.349; JRAVVMHGQVQNIQ-UHFFFAOYSA-N; [M+NH4]+; [2-(oxan-2-yl)pyrazol-3-yl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.341; FNUWNALPTXNSAZ-UHFFFAOYSA-N; [M+NH4]+; 3-cyclopentyloxy-1-methylpyrazol-4-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -231.744; ZIJBPFPFSGVPTO; [M+H3N+H]+; 2-amino-6-(3-methylbutyl)-3H-pyrimidin-4-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -232.502; GQUXEPBUPCLZTC; [M+H3N+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -241.004; RYNLBXYARMGYPC; [M+H3N+H]+; 6-Amino-5-butyl-2-methyl-4-pyrimidinol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -252.597; FNHCEZVALREEJW; [M+H3N+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -254.323; NQCPECCCWDWTJJ; [M+H3N+H]+; 2-(diethylamino)-6-methylpyrimidin-4-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -290.233; YLJXZSWHZFXCDY; [M+H]+; Amidinomycin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -291.055; GMHNKGPHJQRSMQ; [M+H3N+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -298.310; CQTKVYHURMMRPR; [M+H3N+H]+; 2-(2-pyrrolidin-2-ylpropyl)-1,3,4-oxadiazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -301.754; DQENLXHRPLSILC; [M+H3N+H]+; 6-Amino-5-pentyl-4-pyrimidinol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -340.534; MGESDKOHGQHZFN; [M+H3N+H]+; Oprea1_123356
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -397.299; ZNXAJGZPUQOEDZ; [M+H3N+H]+; Azepexol
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.082; YLJXZSWHZFXCDY; [M+H]+; Amidinomycin
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.054; ZIJBPFPFSGVPTO; [M+H3N+H]+; 2-amino-6-(3-methylbutyl)-3H-pyrimidin-4-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -70.577; AAOLTPFNNDEBDV; [M+H3N+H]+; 5-ethyl-3-[(3R)-piperidin-3-yl]-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -74.417; GLVWSYIZOMCMSB; [M+H3N+H]+; 5-Ethyl-3-(piperidin-4-yl)-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -79.411; RMSOAYFDGCWQTF; [M+H3N+H]+; N-[2-(3-methyl-1,2,4-oxadiazol-5-yl)ethyl]but-3-en-1-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -81.181; UIVPKOOMHSYUNJ; [M+H3N+H]+; 5-methyl-3-[[(3S)-piperidin-3-yl]methyl]-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -81.443; VCSHDKSXQADDBK; [M+H3N+H]+; 5-Propyl-3-(pyrrolidin-3-yl)-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -83.007; YUNTVXGBYBLEKS; [M+H3N+H]+; 5-Methyl-3-(piperidin-4-ylmethyl)-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -83.526; AJMJHXSVFSAAIE; [M+H3N+H]+; 5-(Azetidin-3-yl)-3-butyl-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -83.749; OJMOVGYMYHLYKW; [M+H3N+H]+; N-[(3-cyclobutyl-1,2,4-oxadiazol-5-yl)methyl]ethanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -83.941; VKJWYEOXKNMDQA; [M+H3N+H]+; N-[(3-cyclopropyl-1,2,4-oxadiazol-5-yl)methyl]propan-1-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -84.310; WPWOFZLFFOKMOX; [M+H3N+H]+; 2-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-N-ethylethanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -279.076; AQHIJHIPSFYROC; [M+H]+; 1-(N'-cyclohexylcarbamimidoyl)-3-methylurea
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -361.259; YLJXZSWHZFXCDY; [M+H]+; Amidinomycin
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.247; AAOLTPFNNDEBDV; [M+H3N+H]+; 5-ethyl-3-[(3R)-piperidin-3-yl]-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.024; AQHIJHIPSFYROC; [M+H]+; 1-(N'-cyclohexylcarbamimidoyl)-3-methylurea
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C9H19N4O1; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 14.859
MS$FOCUSED_ION: PRECURSOR_M/Z 199.155214
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-03dj-2900000000-44b27d347fe94dfddf64
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  55.0542418 13.2145 55.054871 2.0162 3.39 -0.0055 13 f{C4H7}/0.28ppm,p-C5H12N4O1
  69.0699015 403.2318 69.070527 0.3185 39.49 0.2941 16 f{C5H9}/0.36ppm,p-C4H10N4O1
  71.0490354 28.8122 71.049649 1.2104 8.36 -0.4147 16 f{C4H7O1}/-1.49ppm,p-C5H12N4
  71.0602912 46.7981 71.060904 1.4635 10.27 0.4000 16 f{C3H7N2}/-1.17ppm,p-C6H12N2O1
  72.0443122 24.3635 72.044919 1.1937 6.85 0.4071 15 f{C3H6N1O1}/-1.08ppm,p-C6H13N3
  74.0964318 132.5370 74.097023 0.7558 14.55 0.3206 16 f{C4H12N1}/0.08ppm,p-C5H7N3O1
  83.0602757 20.0725 83.060779 2.0708 4.73 0.0088 16 f{C4H7N2}/-1.19ppm,p-C5H12N2O1
  83.0854197 16.7308 83.085923 1.4443 3.93 0.3901 13 f{C6H11}/-1.29ppm,p-C3H8N4O1
  85.0759302 32.1836 85.076409 1.3517 5.59 0.3529 16 f{C4H9N2}/-1.11ppm,p-C5H10N2O1
  86.0600433 110.7460 86.060510 0.7553 8.36 0.6118 16 f{C4H8N1O1}/0.04ppm,p-C5H11N3
  87.0916550 61.3830 87.092108 0.9989 10.10 0.3647 16 f{C4H11N2}/-0.23ppm,p-C5H8N2O1
  97.0760325 21.7165 97.076378 2.0808 5.76 -0.2235 16 f{C5H9N2}/0.08ppm,p-C4H10N2O1
  99.0915930 20.6551 99.091922 1.8569 5.05 0.2264 14 f{C5H11N2}/-0.83ppm,p-C4H8N2O1
  100.0756376 43.6599 100.075959 0.9992 8.91 -0.2235 16 f{C5H10N1O1}/-0.53ppm,p-C4H9N3
  111.0917406 116.5829 111.091956 0.9722 14.43 0.5294 16 f{C6H11N2}/0.59ppm,p-C3H8N2O1
  111.1168528 740.8239 111.117068 0.2610 61.19 0.4088 16 f{C8H15}/0.23ppm,p-C1H4N4O1
  113.0708071 17.7792 113.071001 2.7947 4.71 0.0500 15 f{C5H9N2O1}/-1.17ppm,p-C4H10N2
  113.1073262 156.1026 113.107519 0.3802 21.22 0.7294 16 f{C6H13N2}/0.01ppm,p-C3H6N2O1
  114.1026188 166.6861 114.102801 0.4470 12.81 0.6353 16 f{C5H12N3}/0.39ppm,p-C4H7N1O1
  115.0865952 72.2088 115.086766 0.9819 12.02 0.4765 16 f{C5H11N2O1}/0.05ppm,p-C4H8N2
  115.1229588 37.7647 115.123129 1.8415 5.67 0.7294 16 f{C6H15N2}/-0.14ppm,p-C3H4N2O1
  125.0710017 34.4225 125.071043 1.3912 7.06 0.2706 16 f{C6H9N2O1}/0.50ppm,p-C3H10N2
  127.0865911 42.6315 127.086604 0.7711 7.59 0.6059 16 f{C6H11N2O1}/0.01ppm,p-C3H8N2
  127.1104309 28.0294 127.110443 1.3060 7.94 0.0412 16 f{C6H13N3}/0.25ppm,p-C3H6N1O1
  129.1021910 47.4241 129.102174 1.4562 7.85 0.3088 16 f{C6H13N2O1}/-0.38ppm,p-C3H6N2
  139.0865718 27.1409 139.086477 1.7687 7.05 -0.0929 15 f{C7H11N2O1}/-0.13ppm,p-C2H8N2
  139.1231251 20.6902 139.123030 1.9048 5.08 -0.0214 15 f{C8H15N2}/1.08ppm,p-C1H4N2O1
  154.0974442 27.9327 154.097339 2.5244 7.91 0.4265 16 f{C7H12N3O1}/-0.29ppm,p-C2H7N1
  156.1496361 27.8923 156.149530 1.9469 8.21 0.0637 14 f{C8H18N3}/0.72ppm,p-C1H1N1O1
  158.1538961 29.0698 158.153789 1.9981 7.02 0.2235 16 ?
  181.1447527 379.2726 181.144631 0.2871 25.05 0.6441 16 f{C9H17N4}/-0.11ppm,p-H2O1
  182.1289021 29.4248 182.128779 2.5971 7.12 -0.0412 16 f{C9H16N3O1}/0.62ppm,p-H3N1
  182.1653548 17.8236 182.165232 3.0412 4.63 0.3451 14 ?
  199.1229269 42.2893 199.122794 2.4909 7.32 0.1341 14 ?
  199.1554690 999.0000 199.155336 0.3565 0.00 1.0000 16 f{C9H19N4O1}/0.66ppm,p
  199.1785315 101.5484 199.178398 2.6609 21.26 -0.1647 16 ?
  199.1925890 114.6494 199.192456 2.2039 22.89 0.5471 16 ?
PK$NUM_PEAK: 37
PK$PEAK: m/z int. rel.int.
  55.054242 13.21 13
  69.069901 403.23 403
  71.049035 28.81 28
  71.060291 46.80 46
  72.044312 24.36 24
  74.096432 132.54 132
  83.060276 20.07 20
  83.085420 16.73 16
  85.075930 32.18 32
  86.060043 110.75 110
  87.091655 61.38 61
  97.076033 21.72 21
  99.091593 20.66 20
  100.075638 43.66 43
  111.091741 116.58 116
  111.116853 740.82 740
  113.070807 17.78 17
  113.107326 156.10 156
  114.102619 166.69 166
  115.086595 72.21 72
  115.122959 37.76 37
  125.071002 34.42 34
  127.086591 42.63 42
  127.110431 28.03 28
  129.102191 47.42 47
  139.086572 27.14 27
  139.123125 20.69 20
  154.097444 27.93 27
  156.149636 27.89 27
  158.153896 29.07 29
  181.144753 379.27 379
  182.128902 29.42 29
  182.165355 17.82 17
  199.122927 42.29 42
  199.155469 999.00 999
  199.178531 101.55 101
  199.192589 114.65 114
//
